Article

In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2

2023-08-11

Abstract excerpt

Covid-19 is one of humanity’s biggest threat in the 21st century with WHO figures reporting 636 million cases and up to 6.6 million deaths globally. SARS-CoV-2, the virus that causes the Covid-19 disease, is characterized by high mutation which contributes to its rapid spread. While several vaccines have been produced to minimize the severity of the coronavirus and diverse treatment regimens have been approved by...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8ba67600-db46-55f7-add4-1129a3ade1f1
DOI: 10.20944/preprints202308.0887.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2DOI 10.20944/preprints202308.0887.v1Read

Virtual Screening Based Prediction of Potential Drugs for COVID-19Semantic proximity Read

Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studiesSemantic proximity Read

Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)Semantic proximity Read

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity Read

Repurposing drugs for treatment of SARS-CoV-2 infection: Computational design insights into mechanisms of actionSemantic proximity Read

In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2Semantic proximity Read

Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 targetSemantic proximity Read

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studiesSemantic proximity Read

Drug repurposing for SARS-CoV-2: a high-throughput molecular docking, molecular dynamics, machine learning, and DFT studySemantic proximity Read

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read

In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics SimulationsSemantic proximity Read

Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19Semantic proximity Read